Significant reductions seen in blood pressure and LDL-C at six and 12 months for patients enrolled in remote program<\/p>\n<\/h3>\n
<\/b><\/p>\n
<\/b><\/p>\n
WEDNESDAY, Nov. 9, 2022 (HealthDay News) — A remotely delivered hypertension and cholesterol management program is effective for reducing blood pressure (BP) and low-density lipoprotein cholesterol, according to a study published online Nov. 9 in JAMA Cardiology<\/em>.<\/p>\n Alexander J. Blood, M.D., from Brigham and Women’s Hospital in Boston, and colleagues implemented and evaluated a remote hypertension and cholesterol management program among 10,803 patients across a diverse health network (3,658 with hypertension; 8,103 with cholesterol; and 958 with both). A total of 1,266 patients requested education only; other enrolled patients received education, home BP device integration, and medication titration. Overall, 424,482 BP readings and 139,263 laboratory reports were collected.<\/p>\n The researchers found that the mean clinic BP at six and 12 months after enrollment decreased by 8.7\/3.8 and 9.7\/5.2 mm Hg, respectively, for those engaged in remote medication management. The corresponding changes in BP were \u00e2\u0088\u00921.5\/\u00e2\u0088\u00920.7 and +0.2\/\u00e2\u0088\u00921.9 mm Hg in the education-only cohort. Patients in remote medication management experienced a mean reduction in low-density lipoprotein cholesterol of 35.4 and 37.5 mg\/dL at six and 12 months, respectively, in the lipids program. The mean reductions in the education-only cohort were 9.3 and 10.2 mg\/dL, respectively. The rates of enrollment and reductions in BP and lipids were similar across racial, ethnic, and primary language groups.<\/p>\n “Patients want innovative solutions to more easily engage with the health system,” a coauthor said in a statement. “Our program provides strong evidence that remote care can work and can make a difference in patients’ lives.”<\/p>\n Several authors disclosed financial ties to the pharmaceutical industry; the work was partially sponsored by AllWays Health Partners.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n Editorial (subscription or payment may be required)<\/a><\/p>\n <\/i><\/p>\n